A Hollywood “ketamine pipeline” that ended in Matthew Perry’s death just drew a 15-year federal sentence—showing how lethal “party drugs” become when dealers run organized supply chains.
Story Snapshot
- Jasveen Sangha, dubbed the “Ketamine Queen,” was sentenced to 15 years in federal prison on April 8, 2026, for supplying ketamine tied to Matthew Perry’s fatal overdose.
- Federal prosecutors described a long-running, home-based drug operation in North Hollywood that sold ketamine and other narcotics through middlemen.
- Court records indicate Perry received multiple batches of ketamine in October 2023, with his assistant administering repeated injections leading up to his death.
- Five defendants were charged in the broader case; guilty pleas resolved most of it, while sentencing for the remaining defendants was still pending this month.
Federal judge hands down 15 years after guilty plea
U.S. District Judge Sherilyn Peace Garnett sentenced British-American drug dealer Jasveen Sangha to 15 years in federal prison in Los Angeles on April 8, 2026.
Sangha had pleaded guilty to five federal charges, including distribution of ketamine resulting in death, a plea that avoided a trial previously set for September 2026. Prosecutors sought a lengthy term, while the defense argued for leniency based on addiction and rehabilitation claims.
Federal reporting describes Sangha as the third of five defendants to be sentenced in the case. Two defendants were described as still awaiting sentencing later in April 2026, including Perry’s assistant.
The case drew national attention because it tied an underground ketamine supply network to a high-profile death, raising questions about how easily controlled substances circulate among wealthy clients and the people paid to manage their daily lives.
How investigators say ketamine moved from dealer to celebrity
Investigators traced the ketamine to Sangha through a chain of intermediaries rather than a direct handoff. According to the outlined timeline, Perry received 25 vials on Oct. 14, 2023, and another 25 vials on Oct. 24.
Authorities say his assistant administered injections multiple times per day, and the fatal dose was ultimately drawn from the supply attributed to Sangha’s operation, which prosecutors said ran out of her North Hollywood home.
Jasveen Sangha, known as the “Ketamine Queen,” was sentenced to 15 years in prison for selling the ketamine that killed Matthew Perry in 2023.
She pleaded guilty last year to five federal charges tied to his death and has been in federal custody since her 2024 arrest.… pic.twitter.com/RU7iBR17kI
— Variety (@Variety) April 8, 2026
In addition to ketamine, the operation was described as selling drugs such as cocaine and methamphetamine. Prosecutors characterized the business as elaborate and profit-driven, while the defense emphasized Sangha’s personal struggles.
In court, Sangha said she accepted responsibility and spoke about addiction. The sentencing outcome—15 years rather than the much higher maximum exposure cited in coverage—reflects how federal guidelines, plea agreements, and judicial discretion often shape drug-death cases.
The “death resulting” charge and what it signals for enforcement
The central legal hook in this case was the “death resulting” component attached to ketamine distribution, a charge that can sharply increase penalties when prosecutors prove a direct connection between the supplied drug and a fatality.
Ketamine is a Schedule III controlled substance with legitimate medical use, but the case underscores how dosage, setting, and repeated unsupervised injections can turn a controlled substance into a lethal product when it’s sold and used outside medical oversight.
From a public-safety perspective, the facts laid out in reporting point to a familiar pattern: a supplier at the top, intermediaries who deliver and insulate the source, and a final link—often an assistant or friend—who administers drugs and becomes exposed to criminal liability.
The case does not resolve broader cultural problems in celebrity circles, but it does show that federal prosecutors are willing to use serious charges when investigators can map a supply chain.
A prior overdose admission adds weight to prosecutors’ narrative
Prosecutors also pointed to Sangha’s admitted involvement in a separate 2019 incident in which she sold ketamine vials to Cody McLaury hours before he died of an overdose. That death was described as unrelated to Perry’s case, but it added context for prosecutors arguing Sangha was not a one-time participant.
Coverage also noted some unrelated charges were dropped, a reminder that prosecutors often narrow cases to the most provable counts when a defendant pleads guilty.
For families watching from the gallery, the sentencing hearing served as a moment of accountability, with victim-impact testimony reported in coverage. For the rest of the country, the larger takeaway is less about Hollywood gossip and more about enforcement reality: when illegal distribution intersects with death, federal prison time can be substantial—even when a defendant avoids trial through a plea.
Sentencing for the remaining defendants was still pending, limiting what can be concluded about final case outcomes.
Sources:
https://en.wikipedia.org/wiki/Jasveen_Sangha
